Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study.
Eun-Jeong GongHye Kyung JungBora LeeJitaek HongJong Wook KimCheol Min ShinYoung Hoon YounKwang Jae LeePublished in: Alimentary pharmacology & therapeutics (2023)
Long-term PPI use is associated with an increased risk of metachronous gastric cancer in patients who undergo H. pylori eradication therapy after endoscopic resection of gastric neoplasms.